A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b
NCT00423644
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Darinaparson
Sponsor
Alaunos Therapeutics